Article content
The Human Rights Report reinforces the company’s commitment to the United Nations Guiding Principles on Business and Human Rights
Lausanne, Switzerland – Philip Morris International (PMI) (NYSE: PM) today released its first Human Rights Report, detailing the company’s strategy to promote, respect and protect human rights, and its progress to date in implementing human rights. Commitment to human rights.
Article content
PMI’s commitment to human rights is the cornerstone of its human rights strategy. It sets out fundamental principles that must be respected at all stages of operations and the value chain, by both PMI and its business partners. In 2022, Philip Morris International (PMI) updates its commitment to the latest company prominence mapping, assessment of sustainability materiality, ongoing due diligence activities, and the evolution of the company’s sustainability strategy.
Advertising 2
This ad hasn’t been uploaded yet, but your article continues below.
Article content
“Creating a strong foundation and integrating mechanisms into our organization that promote, respect and protect human rights is an essential part of our approach to business,” said Jacek Olczak, CEO. “While this can be challenging given the breadth of our operations and the scope and complexity of the issues involved, we believe human rights are an absolute and universal demand that we are committed to upholding.”
In the Human Rights Report, Philip Morris International shares best practices, lessons learned, key challenges, and future actions. It also features country case studies and external recognition – such as the inclusion of PMI’s agricultural labor practices in the most recent work of the World Business Council for Sustainable Development (WBCSD) Human rights progress report. PMI actively participates in the Business Committee’s efforts to address inequality (BCTI) and contributed to a recent report on Tackling Inequality: An Agenda for Business.
In addition, the Project Management Institute (PMI) Human Rights Report includes progress towards its 2025 goal of conducting 10 Human Rights Impact Assessments (HRIAs) in the most vulnerable countries. To date, PMI has completed seven HRIAs, including two in 2022 in Brazil and Malaysia. Read more about HRIAs PMI here.
PMI’s approach to human rights is anchored in the United Nations Guiding Principles on Business and Human Rights (UNGPs), and the strategy is centered on four pillars:
- sound frame: PMI’s human rights work is governed by the PMI Human Rights Commitment, which is implemented by other PMI policy tools such as the Company’s Code of Conduct. Raising awareness of these tools helps PMI embed the spirit of respect for human rights into the company’s culture.
- Strict due diligence: PMI has robust programs and processes in place to identify negative impacts across its value chain.
- treatment: In the event of adverse impacts, PMI strives to ensure access to grievance mechanisms.
- Transparency: Transparently reporting on PMI’s progress and challenges through its annual reports and targeted communications is a vital component of its approach.
“Human rights are inherent in the dignity of human life and a prerequisite for the prosperity of society,” said Jennifer Mottles, Head of Sustainability. As a global company, we work to uphold human rights within our organization and across our value chain. We will continue to work with different parts of society in a multi-stakeholder approach to achieve sustainable solutions that comprehensively address systemic human rights issues.”
Advertising 3
This ad hasn’t been uploaded yet, but your article continues below.
Article content
To read the Project Management Institute’s Human Rights Report, visit www.pmi.com/human-rights-report. To learn more about PMI’s sustainability journey, please visit www.pmi.com/sustainability. Or you can access the company’s additional sustainability resources: Integrated PMI Report 2022And Agricultural Work Practices ProgramAnd Sustainability Index PMI and ESG KPI.
In this release and in related communications, the terms “material,” “material,” and similar terms, when used in the context of economic, environmental, and social topics, are defined in the indicated sustainability criteria, and are not intended to conform to the concept of materiality under securities laws and/or or US disclosures required by the US Securities and Exchange Commission. The aspirational goals and objectives in this release do not constitute financial projections.
Philip Morris International: Introducing a smoke-free future
Philip Morris International (PMI) is a leading international tobacco company working on a smoke-free future and developing its long-term portfolio to include products outside the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested more than $10.5 billion to develop, scientifically prove and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of ending the sale of cigarettes altogether. This includes building world-class scientific assessment capabilities, particularly in the areas of pre-clinical system toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, PMI acquired Swedish Match – a leading oral nicotine delivery company – creating a global smoke-free business led by the IQOS and ZYN brands. The US Food and Drug Administration (FDA) has approved versions of IQOS Platform 1 devices and consumables from PMI and Swedish Match Risk Modified Tobacco Products (MRTPs). As of March 31, 2023, PMI’s smoke-free products were available for sale in 78 markets. PMI estimates that approximately 18.5 million adults worldwide have already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 35% of PMI’s total first-quarter 2023 net revenue. With a strong foundation and significant experience in life sciences, PMI announced in February 2021 its ambition to expand into the areas of health and wellness, and through its business Vectura Fertin Pharma aims to enhance lives by offering seamless health experiences. For more information, please visit the website www.pmi.com And www.pmiscience.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230619909205/ar/
Contacts
David Fraser
Philip Morris International
Tel. +41 (0) 58242 4500
E.david.fraser@pmi.com
#destro
comments
Postmedia is committed to maintaining an active and civil forum for discussion and encouraging all readers to share their opinions on our articles. Comments may take up to an hour to be moderated before they appear on the site. We ask that you keep your comments relevant and respectful. We’ve enabled email notifications – you’ll now receive an email if you get a response to your comment, if there’s an update to a comment thread you’re following or if it’s a user you’re following. Visit our Community Guidelines for more information and details on how to adjust your email settings.
Join the conversation